Share Name Share Symbol Market Type Share ISIN Share Description
Advanced Onco LSE:AVO London Ordinary Share GB00BD6SX109 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +0.00p +0.00% 38.00p 36.00p 40.00p 38.00p 38.00p 38.00p 37,383 08:00:00
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Real Estate Investment & Services 0.0 -16.5 -17.6 - 64.44

Advanced Onco Share Discussion Threads

Showing 5126 to 5149 of 5350 messages
Chat Pages: 214  213  212  211  210  209  208  207  206  205  204  203  Older
DateSubjectAuthorDiscuss
09/5/2018
07:12
Andy: I absolutely have faith in this. Cheers.
paul_98
09/5/2018
05:40
JacNife I think you will be able to see the shares issued to Yantai CIPU here: hxxp://www.4-traders.com/ADVANCED-ONCOTHERAPY-PLC-4006264/company/ I am pleased I can sleep at night as there are certainly a large number of skeptical posters who I guess must have unfortunately lost out in the past with this company. However for me I see a completely new horizon and this company now has some of the best professionals in the world working with them. In addition we have some seriously wealthy shareholders backing the company, for me following the money has paid off and I am really excited with what they are doing and the expertise around them. GLA. Lets see what the next news brings.
makeamillion1
09/5/2018
00:55
makeamillion - "most important treating superficial tumors by the end of Q3 this year has been reaffirmed as on track in the RNS today." They still won't be actually treating any patients till - at best - late 2020. Most superficial tumours are easily surgically removed = those in critical areas like the eyes are already treated on the NHS by low energy proton therapy, and by 2020 even high energy-capable proton centres will already be available in London and Manchester. I doubt they'll get a smooth enough flow of private patients at Harley St to make an operating profit. When and if AVO produces and certifies its full power units I doubt there'll be any firm commercial orders until/unless they've been demonstrated to be as reliable as the traditional technology.
scantrader
08/5/2018
23:52
Paul, Exactly, who worries about little trivialities like whether funds have actually arrived or not?
andy
08/5/2018
22:21
makeamillion1 Looking at the share register Yantai CIPU Medical Technology Co.Ltd have currently 24,199,622 shares (16.1%) Where are you "looking at the share register"? I'm looking (a) here: Https://www.avoplc.com/Investor-Relations/Shareholder-Analysis Which fails to mention their name at all and if it's not definitive then the BOD are in breach of AIM rules. And: (b) here: Https://www.investegate.co.uk/Index.aspx?searchtype=3&words=avo Which fails to show any RNS announcing a holding for Yantai CIPU for either 16.1%, 29.9% or any other percentage. which I assume is not the full share allocation of 30% until the second payment for the distribution deal has been completed and the second payment of £16.5m received. Although this is pure speculation on my part as we do not have full sight of the Agreements signed in December. This RNS: Https://www.investegate.co.uk/advanced-oncotherapy--avo-/rns/distribution-agreement-and-equity-investments/201712070700056613Y/ Makes clear that all 45m shares were expected to be issued upon receipt of the £13.5m The conclusion is obvious: the cash hasn't been received. JakNife
jaknife
08/5/2018
22:12
JakNife, I think we will just agree to differ although I appreciate your view. Looking at the share register Yantai CIPU Medical Technology Co.Ltd have currently 24,199,622 shares (16.1%) which I assume is not the full share allocation of 30% until the second payment for the distribution deal has been completed and the second payment of £16.5m received. Although this is pure speculation on my part as we do not have full sight of the Agreements signed in December. It would seem quite extraordinary however to issue any shares without the receipt of funds and the company having received the first payment of £13.5m and with Yantai CIPU having 16.1% of the issued share capital may explain why no TR1 has been issued yet. I can see the total shares are now 150,501,673 as detailed in the 16th February 2018 RNS, I can also see a float of 63,550,474 shares (42.2%). What we do not know is what contingencies were written into the Agreement signed in December 2017 with respect to delays or not completing the distribution agreement, but I would expect there to have been some contractual obligations to complete the deal as a whole. In addition I would expect Mrs. Zhang RenHua and Mr. Chunlin Han will be appointed following the completion of the entire agreement announced on 7th December 2017 and following the required due diligence I am not sure there is any other explanation, but perhaps you or anyone else may have other comments or knowledge.
makeamillion1
08/5/2018
20:25
I believe in them. It’s all going great in my eyes. I live in the present and then on to the future, which looks damn good to me! GLA
paul_98
08/5/2018
20:18
makeamillion1, Please read this section of the 16th February release: "As a consequence of the completion of the Subscription by Yantai Cipu,... So you're 100% happy that the money has definitely been received? Are you certain that that announcement actually says that the money has been received? If it has been received then: 1. Why hasn't Yantai Cipu issued a TR1 for its near 30% stake? 2. Why haven't Mrs. Zhang RenHua and Mr. Chunlin Han been appointed to the board of AVO to represent Yantai Cipu, as announced in the circular? 3. If the money has arrived then why hasn't AVO used the funds to repay the Blackfinch secured loan, which was due to be repaid at the end of March and hence AVO is currently in default on? If you check Companies House you can see that the loan hasn't been repaid. I suggest that you read the announcement again because it actually says "the Company has been informed by Yantai Cipu that the Chinese authorities have authorised the transfer from China of the £13,500,000 payable by Yantai Cipu" and doesn't say that the money has actually been paid or been received. Personally, my conclusion is that the money hasn't arrived. It's the only explanation that adequately meets the facts. And that means that once again AVO are pulling the wool over shareholders' eyes by deliberately hiding the truth from them ... just like last time. JakNife
jaknife
08/5/2018
18:28
The shares have already been issued they would not have been issued without receipt of funds, this is standard practice and is never followed by another announcement because the announcement is the issuing of shares. Please read this section of the 16th February release: "As a consequence of the completion of the Subscription by Yantai Cipu, and as detailed in the circular dated 22 December 2017 (the "Circular"), the placing of 10,868,782 new ordinary shares with new and existing investors at the Subscription Price (the "Placing"), as well as the conversion of the loan made by Swedish Investors by way of issue of 13,697,697 new ordinary shares (the "Conversion"), have also been completed." The relevant words are the first 3 words "As a consequence" and the last word in the paragraph "completed" If you needed any further comfort the RNS issued on 3rd April confirms their considerable stake in the company......so fear not the company IMO is in very good shape.
makeamillion1
08/5/2018
17:50
That just says the money will be sent. Not that it has arrived. And certainly no holdings RNS issued afterwards. Still in the post I reckon, like a lot of promised Chinese money.
igbertsponk
08/5/2018
17:36
Igbert Completion of subscription and receipt of £13.5m resulting in issue of shares confirmed on 16th February 2018. hxxps://polaris.brighterir.com/public/advanced_oncotherapy/news/rns/story/w647q7x
makeamillion1
08/5/2018
17:30
Do we know for sure that the £13.5m was actually received? Can't see anything definitive... and certainly no major holdings announcement. Not on their website either... hTtp://www.avoplc.com/Investor-Relations/Shareholder-Analysis Chinese money never to be counted on until you can count it out in notes.
igbertsponk
08/5/2018
17:14
makeamillion1. I actually agree with some of what you say. However, I think that AVO is not out of the woods and the share price is likely to be a bit erratic for some time.
daijavu
08/5/2018
08:57
lol really I am loving this ride from 10p - 12p, great news today plus developments with Thales to scale up. I have no concerns whatsoever with the Chinese money not coming through yet, there is no way that Yantai CIPU would have already subscribed for 45 million shares at 30p and paid £13.5 million if they had any doubts at all in their distribution partner. IMHO the distribution licensing partner will be a well known and substantial partner in the Asia region, these things take time and so they should but rest assured when it is announced it will represent IMO another step change in the share. The company currently has sufficient cash to be patient following the raising announced 7th December and as commented on here and other message boards there is much more news flow to come very soon like a further technical update, Circle Life's Birmingham site has been mentioned in previous analyst reviews and is expected to be announced, plus most important treating superficial tumors by the end of Q3 this year has been reaffirmed as on track in the RNS today. The board and team as mentioned in the goetzpartners securities has changed significantly since 2016, it is a totally refocused company and not worthy of comparing to the past. Just highlighting what goetzpartners securities said: "Reinforced management team changes the equity story significantly. AVOs management team has changed the equity story significantly compared to 2016. While the patents and the promising technology was already in place then, the company has added veterans of the PT industry from science, engineering, installation, application experience and compliance. We feel that the success of the industrialisation is entirely hinging on the top professionals." I am looking forward to seeing what the market cap and share price will be following the announcement of superficial tumors being treated Q3 2018.
makeamillion1
08/5/2018
08:38
Igbert. I think you are reading too much into it. I think that Harley Street is still where the first machine will be used. It is just a disappointment that the timeline is so much longer than they promised.
daijavu
08/5/2018
08:26
So, reading between the lines, they hoped to build the thing at Harley Street, but delays there mean they've been forced to rent another site.
igbertsponk
08/5/2018
08:07
It is progress of a sort but where is the Chinese money?
daijavu
08/5/2018
07:41
Fantastic news this morning!
paul_98
06/5/2018
07:33
grahamhacker thanks sounds interesting can you paste the article?
makeamillion1
06/5/2018
07:05
Sorry my last post doesn't provide the correct link. The Sunday Times announcement states that on Tuesday AVO will announce a deal with the Government to open a testing site in Cheshire to help its development.
grahamhacker
06/5/2018
06:47
AVO - Sunday Times todayhttps://www.thetimes.co.uk/article/cambridge-at-war-over-biotech-bid-by-abcam-for-horizon-discovery-sd6thrdx9?shareToken=cea728440164bc237d13aa7a18787274
grahamhacker
03/5/2018
12:04
hTTps://khn.org/news/as-proton-centers-struggle-a-sign-of-a-health-care-bubble/
scantrader
01/5/2018
12:57
I'm happy to be patient and out, long term watch, and yes GLA.
cosmicboy
01/5/2018
12:35
I’m happy to be patient... GLA. Good times ahead I’m convinced. Long term hold.
paul_98
Chat Pages: 214  213  212  211  210  209  208  207  206  205  204  203  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:43 V: D:20181019 00:04:29